文献速递中毒与环境急症呼吸衰竭与机械通气重症综合管理与镇静镇痛

罗库溴铵缩短有机磷杀虫剂中毒后通气时间的初步临床研究

A pilot clinical study of the neuromuscular blocker rocuronium to reduce the duration of ventilation after organophosphorus insecticide poisoning.
PubMed 文献 · Clin Toxicol (Phila) · 2019-07-31
一句话结论在标准治疗基础上加用罗库溴铵并未缩短有机磷中毒患者的插管时间,反而可能延长插管时间并恶化神经肌肉接头功能,目前不推荐用于临床管理。

该初步三臂剂量反应II期试验纳入45例有机磷杀虫剂自服中毒患者,比较罗库溴铵滴定至初始神经肌肉功能抑制>95%(Roc>95,n=15)或50%(Roc50,n=14)加标准治疗与单纯标准治疗(对照,n=16)的疗效。主要终点为插管时间,次要终点为病死率。最常见摄入农药为丙溴磷(29/45,64.4%)。排除死亡患者后,Roc50组(中位259.5小时)和Roc>95组(中位226.8小时)插管时间均显著长于对照组(中位88.5小时,p=.0162和p=.0016)。作者认为罗库溴铵未减少插管时间,可能恶化神经肌肉接头功能,需进一步研究更短疗程方案后方可用于临床。

要点

  • 在标准治疗基础上加用罗库溴铵(初始抑制>95%或50%神经肌肉功能)并未缩短有机磷中毒患者的插管时间。
  • 排除死亡患者后,Roc50组中位插管259.5小时、Roc>95组226.8小时,均显著长于对照组88.5小时(p=.0162和p=.0016)。
  • 病死率各组相似:对照组3/16(18.8%)、Roc50组4/14(28.6%)、Roc>95组2/15(13.3%)(p=.5842)。
  • 最常见摄入农药为丙溴磷(29/45,64.4%),多数患者住院期间丁酰胆碱酯酶活性持续严重抑制。
  • 作者认为罗库溴铵可能恶化神经肌肉接头功能,在进一步临床研究(包括更短疗程方案)之前,烟碱受体拮抗剂不能用于有机磷中毒的临床管理。

适用人群与场景

  • 有机磷杀虫剂自服中毒患者,纳入急诊/ICU住院阶段。

诊断标准与关键阈值

  • 通过加速肌电图监测神经肌肉功能,滴定罗库溴铵至初始抑制>95%或50%。
  • 通过血液分析确认摄入的有机磷杀虫剂种类。

处置流程与药物剂量

  • 罗库溴铵组:先给予罗库溴铵溴化物弹丸式注射,滴定至初始神经肌肉功能抑制>95%(Roc>95组)或50%(Roc50组),随后持续输注罗库溴铵最长120小时,同时给予标准治疗。
  • 对照组:仅给予标准治疗。

研究设计与关键结果

  • 研究类型:初步三臂剂量反应II期试验,样本量45例,随机分为Roc>95组(n=15)、Roc50组(n=14)和对照组(n=16)。
  • 最常见摄入农药为丙溴磷(29/45,64.4%)。
  • 主要终点插管时间(排除死亡患者):Roc50组中位259.5小时[IQR 176-385] vs 对照组88.5小时[IQR 47-160],p=.0162;Roc>95组中位226.8小时[IQR 186-355] vs 对照组88.5小时,p=.0016。
  • 次要终点病死率:总病死率9/45(20%),对照组3/16(18.8%)、Roc50组4/14(28.6%)、Roc>95组2/15(13.3%),p=.5842。
  • 丁酰胆碱酯酶活性:多数患者住院期间持续严重抑制。

证据类型、等级与局限

  • 证据类型:初步剂量反应II期临床试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在本初步研究中,罗库溴铵加标准治疗未减少插管时间,反而可能恶化神经肌肉接头功能。
  • 作者建议,在进一步临床研究(包括测试更短疗程方案)之前,烟碱受体拮抗剂不能用于有机磷中毒的临床管理。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Background: A common manifestation of organophosphorus insecticide self-poisoning is prolonged respiratory failure due to neuromuscular junction dysfunction and likely nicotinic receptor overstimulation. We aimed at collecting preliminary data on whether addition of the competitive nicotinic antagonist rocuronium to standard early therapy might be clinically feasible and associated with reduced duration of ventilation.Methods: A pilot three-arm dose-response phase II trial was set up to compare bolus doses of rocuronium bromide titrated to produce initial >95% or 50% inhibition of neuromuscular function, measured using acceleromyography, plus standard treatment, versus standard treatment alone. After attaining inhibition, patients receiving bolus rocuronium then received rocuronium infusions for a maximum of 120 h. Primary outcome was duration of intubation; secondary outcome was case fatality. Plasma butyrylcholinesterase activity was measured throughout the inpatient stay. Blood was analysed to confirm the organophosphorus insecticide ingested.Results: Forty-five patients were randomised to receive: rocuronium to initially attain 95% inhibition (Roc>95, n = 15), rocuronium to initially attain 50% inhibition (Roc50, n = 14), or no rocuronium (control, n = 16). The most commonly ingested pesticide was profenofos (29/45, 64.4%). Butyrylcholinesterase activity remained severely inhibited for the duration of the study for most patients. Case fatality was 9/45 (20%) and similar across study arms: control 3/16 (18.8%), Roc50 4/14 (28.6%) and Roc>95 2/15 (13.3%) (p = .5842). When excluding patients who died, median [IQR] duration of intubation was significantly longer in the Roc50 (259.5 [176-385] h) and Roc>95 (226.8 [186-355] h) groups compared to controls (88.5 [47-160] h, p = .0162 and p = .0016, respectively).Conclusions: In this pilot dose-response study, we found no evidence that rocuronium in addition to standard therapy reduced the duration of intubation. It is possible that it worsened neuromuscular junction function. Further clinical research, including testing of shorter duration regimens, needs to be performed before nicotinic antagonists can be used in the clinical management of OP poisoning.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Dhanarisi J, Shihana F, Harju K, et al. A pilot clinical study of the neuromuscular blocker rocuronium to reduce the duration of ventilation after organophosphorus insecticide poisoning. Clin Toxicol (Phila). 2019. PMID: 31364415. doi:10.1080/15563650.2019.1643467

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。